Genetically determined blood pressure, antihypertensive medications, and risk of Alzheimer's disease: a Mendelian randomization study.

Ya-Nan OuYu-Xiang YangXue-Ning ShenYa-Hui MaShi-Dong ChenQiang DongLan TanJin-Tai Yu

Published in: Alzheimer's research & therapy (2021)

This MR analysis found evidence that genetically determined lowering BP was associated with a lower risk of AD and CCB was identified as a promising strategy for AD prevention.

Keyphrases

blood pressure
hypertensive patients
magnetic resonance
heart rate
cognitive decline
magnetic resonance imaging
type diabetes
contrast enhanced
skeletal muscle
metabolic syndrome